NIH Approved Institutional Biosafety Committee (IBC) First Meeting Scheduled for January 29
In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines.
NIH IBC Meeting Schedule for January 29 @ MiraVista Diagnostics
The first meeting of the NIH approved IBC (Institutional Biosafety Committee) is scheduled for Monday, January 29, 2018 at 1:00 p.m. ET at MiraVista Diagnostics’ laboratory in Indianapolis, Indiana. Minutes from the committee meeting will be provided upon request once they are available. Please email requests to: firstname.lastname@example.org